Erratum for Rennels et al., Pediatrics 97 (1) 7-13.
PEDIATRICS Vol. 98 No. 1 July 1996, pp. A38
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rennels, M. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rennels, M. B.

Safety and Efficacy of High-dose Rhesus-Human Reassortant Rotavirus Vaccines-Report of the National Multicenter Trial

Margaret B. Rennels MD1, Roger I. Glass MD, PhD2, Penelope H. Dennehy MD3, David I. Bernstein MD4, Michael E. Pichichero MD5, Edward T. Zito PhD6, Michael E. Mack PhD7, Bruce L. Davidson MD, MPH8, Albert Z. Kapikian MD9, and United States Rotavirus Vaccine Efficacy Group

1 Center for Vaccine Development and Department of Pediatrics, University of Maryland School of Medicine, Baltimore
2 Viral Gastroenteritis Section, Respiratory and Enteric Viruses Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
3 Division of Pediatric Infectious Disease, Rhode Island Hospital, Providence
4 J. N. Gamble Institute of Medical Research, Cincinnati, Ohio
5 Department of Pediatrics, University of Rochester Medical Center, Rochester, New York
6 Wyeth-Ayerst Research, Philadelphia
7 Wyeth-Ayerst Research, Philadelphia, currently
8 Wyeth-Ayerst Research, Philadelphia; Division of Pulmonary and Critical Care Medicine, Medical College of Pennsylvania and Hahnemann University, Philadelphia
9 Labratory of infectious Diseases, National Institutes of Health, Bethesda, Maryland

In the January 1996 article titled "Safety and Efficacy of High-dose Rhesus Human Reassortant Rotavirus Vaccines—Report of the National Multicenter Trial" (Rennels et al. Pediatrics, 1996:97:7-13), the Acknowledgments section on page 12 included an incorrect location for one member of the United States Rotavirus Vaccine Efficacy Group, and another member was inadvertently omitted.

The correct list should include: Stephen Fries, MD, Boulder Medical Center, Boulder, CO; and Hervey Froehlich, MD, Kaiser Permanente Medical Office, Fresno, CA.